tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
RLAY is currently covered by 7 analysts with an average price target of $17.82. This is a potential upside of $10.96 (159.77%) from yesterday's end of day stock price of $6.86.
Relay Therapeutics 's activity chart (see below) currently has 115 price targets and 82 ratings on display. The stock rating distribution of RLAY is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 10.44% with an average time for these price targets to be met of 27.91 days.
Highest price target for RLAY is $20, Lowest price target is $10, average price target is $13.67.
Most recent stock forecast was given by BRADLEY CANINO from STIFEL on 03-Sep-2025. First documented stock forecast 09-Aug-2020.
Currently out of the existing stock ratings of RLAY, 14 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$15
$8.14 (118.66%)
1 months 22 days ago
(03-Sep-2025)
0/8 (0%)
$11 (275.00%)
Buy
$14
$7.14 (104.08%)
$16
2 months ago
(25-Aug-2025)
2/23 (8.7%)
$10.46 (295.48%)
29
Buy
$11
$4.14 (60.35%)
$21
5 months 13 days ago
(12-May-2025)
1/9 (11.11%)
$8.17 (288.69%)
4
Buy
$10
$3.14 (45.77%)
$28
5 months 19 days ago
(06-May-2025)
1/4 (25%)
$7.05 (238.98%)
98
Buy
$12
$5.14 (74.93%)
$21
7 months 28 days ago
(27-Feb-2025)
0/12 (0%)
$8.59 (251.91%)
What is RLAY (Relay Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on RLAY (Relay Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on RLAY (Relay Therapeutics )?
Which analyst is the currently most bullish on RLAY (Relay Therapeutics )?
Which analyst is the currently most reserved on RLAY (Relay Therapeutics )?
